Trending Stocks, Investing Tips, and Market Insights on Stockchase

Mike Vinokur, CFA, CMT, and CFP
Mike Vinokur, CFA, CMT, and CFP on Market Call (BNN TV)05/08/2026 at 12:13am

GLOBAL LARGE

unlockUnlock Rating
Canadian banks to correct?

Yes, the PEs are very high and the dividends are very low historically. Any blip in the economy or credit could mean earnings will take a beating. There's little margin of safety on the earnings. Take profits on the banks if you're collecting a huge profit. He doesn't own the Canadian banks now. How much can earnings growth in this Canadian economy?

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

The Panic-Proof Portfolio (Stockchase Research)
The Panic-Proof Portfolio (Stockchase Research) on Stockchase04/08/2026 at 08:39pm

GLOBAL

unlockUnlock Rating
Stockchase Research Editor: Michael O'Reilly

Gold is always a good holding in your portfolio.  AAAU holds nothing but physical gold (held in trust by the Royal Canadian Mint) and only charges 0.18% MER.  We recommend setting a stop-loss at $34, looking to achieve $48 -- upside potential over 18%.  Yield 0%

Jim Cramer - Mad Money
Jim Cramer - Mad Money on Mad Money on CNBC04/08/2026 at 01:28am

US EQUITIES

unlockUnlock Rating

Was up 23.9% last month. Medtech has slumped for a while, but is rallying now as investors look for tech growth outside AI stocks. They reported a good quarter last week. Wished the PE were lower.

premiumPremium content

It's a Monthly Gems opinion which is available only for Stockchase Premium

Curated by Allan Tong since 2019.
99+ opinions with 4.15 rating.

The Monthly Gems by Allan Tong
The Monthly Gems by Allan Tong on Stockchase03/08/2026 at 11:31pm

NORTH AMERICAN

unlockUnlock Rating

This pharma company is a major holding within XLV, but worth owning itself. The company just reported Q2 earnings, with total net revenues beating, bolstered by 10.2% sales growth. To replace its blockbuster drug, Humira, AbbVie launched Skyrizi which boasts global sales of $5.5 billion, and Rinvoq (global sales of over $2.5 billion). AbbVie's overall sales growth was 10.2%.

Most Anticipated Earnings: OLA-T, SU-T and more Canadian Companies Reporting Earnings this Week (Aug 03-07)
03/08/2026 at 12:08pm

Most Anticipated Earnings: OLA-T, SU-T and more Canadian Companies Reporting Earnings this Week (Aug 03-07)

Here are the Canadian companies listed on Stockchase who are reporting earnings this week: 🛢Basic Materials ⚡ Energy 🏛 Financials 💻 Technology 👨‍⚕️ Healthcare 🚚 Industrials 🛍 Consumer 💡 Utilities Use this list wisely to identify buying opportunities.Happy trading !!! read more